LekoskopLekoskop
UK · ES · FR · CS · IT · NL · CH · HR · PL

New approvals — United Kingdom

MHRA medicines recalls and defect notifications with batch numbers, Serious Shortage Protocols, new approvals and Drug Safety Update — updated daily, automatically. Last updated: 2 Oct 2026 08:50.

All Recalls and defects2 Serious shortages (SSP)2 New approvals1 Drug Safety Update

Sources: we track changes based on information published by the MHRA — medicines recalls and defect notifications, Drug Safety Update and approval announcements — and the Serious Shortage Protocols published by the NHS Business Services Authority. The UK is outside the EU, so European Commission decisions are not listed here.

24 Feb 2026Tuesday 24 February 2026

open day ◀ ▶ 1 event
As with any medicine, the MHRA will keep the safety and effectiveness of imlunestrant tosylate under close review.
What this means, batches, details

Loading…

2 Jan 2026Friday 2 January 2026

open day ◀ ▶ 1 event
As with any medicine, the MHRA will keep the safety and effectiveness of zapomeran under close review.
What this means, batches, details

Loading…

19 Dec 2025Friday 19 December 2025

open day ◀ ▶ 1 event
MHRA approval lenacapavir
As with any medicine, the MHRA will keep the safety and effectiveness of lenacapavir under close review.
What this means, batches, details

Loading…

2 Dec 2025Tuesday 2 December 2025

open day ◀ ▶ 1 event
MHRA approval tisotumab vedotin
As with all licensed medicines, we will continue to monitor its safety closely as it becomes more widely used
What this means, batches, details

Loading…

26 Nov 2025Wednesday 26 November 2025

open day ◀ ▶ 1 event
MHRA approval inavolisib
The MHRA has today, 26 November 2025, approved inavolisib (Itovebi) for the treatment of adults with a type of breast cancer called HR-positive
What this means, batches, details

Loading…

In total 34 events in this category.